Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-25 @ 8:56 PM
Study NCT ID:
NCT04239092
Status:
TERMINATED
Last Update Posted:
2025-07-17
First Post:
2020-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
9-ING-41 in Pediatric Patients With Refractory Malignancies.
Sponsor:
Actuate Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-07
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-20
First Submit QC Date:
None
Study First Post Date:
2020-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-15
Last Update Post Date:
2025-07-17
Last Update Post Date Type:
ACTUAL